Top 20 Medical Device Companies Based on 2018 Revenue

Top 20 Medical Device Companies Based on 2018 Revenue

The Medical device market is growing with greater needs of patients and with their emerging diseases. 2018 has shown major advancement in medical device needs and upgrades with 55 novel drug approvals. The year 2018 has shown a slight change in the ledger of top 20 firms while Medtronic holds its first position with a generated revenue of $30.55B in the global market of the top 20 medical device firms. Our team at PharmaShots has compiled a list of top 20 medical devices companies based on their 2018 total revenue.

Medical Device Revenue: $5.46B                                         Total Employees: ~ 25,378

Founded Year: 1921                                                                   Stock Exchange: Tokyo Stock Exchange

Market Cap: $21.4B                                                                   Headquarters: Tokyo, Japan

 Terumo Corporation is a Tokyo based firm divided into four segments: Interventional systems, Terumo Business System, Medical Products and Pharmaceutical Solutions. In Jul’18 Terumo acquired Essen Technology with its Drug-Eluting Stent (DES) to expand its footprints in markets of China. Additionally, Vascutek And Bolton Medical collaborated to form a firm Terumo Aortic focusing on the global aortic and vascular implants market.

Medical Device Revenue: $6.02B                                          Total Employees: ~93,516

Founded Year: 1902                                                                    Stock Exchange: NA

Market Cap: NA                                                                            Headquarters: Minnesota, United States

The 3M Company, formerly known as the Minnesota Mining and Manufacturing Company, is an American multinational company that focusses on Dental, Skin and wound care, Surgical solutions, personal care products. In Dec’18 3M acquired the technology business of M*Modal to expand its own Health Information system and is expected to close in H1’19.

Medical Device Revenue: $7.10B                                         Total Employees: ~ 20,000

Founded Year: 1945                                                                   Stock Exchange: SWX

Market Cap: ~$28.17B                                                              Headquarters: Geneva, Switzerland

Alcon is a global leader in eye care business and having a complementary business in Surgical and Vision Care, to treat disorders related to the eye. Alcon’s surgical portfolio includes technologies and devices for cataract, retinal, refractive surgery, ATIOLs to treat cataracts and refractive errors, like presbyopia and astigmatism. Additionally, the vision care portfolio includes multiple daily disposable, reusable and color-enhancing contact lenses and a comprehensive portfolio of ocular health products. In H2’18 Alcon acquired Tear Film Innovations for its iLux Medical Device and planned to develop SMART Suite Equipment for improving cataract surgery.

Medical Device Revenue: $7.23B                                         Total Employees: ~ 35,933

Founded Year: 1919                                                                   Stock Exchange: Tokyo

Market Cap: ~$16.47B                                                              Headquarters: Tokyo, Japan 

Olympus Corporation is a Japanese manufacturer of optics and reprography products. Olympus also has a portfolio of multiple technologies like Optical, Opto-Digital, Precision including Bio-science and Digital Imaging. In Oct’18 the company acquired LPixel aiming to focus on AI-technologies to support endoscopic and microscopic diagnostic imaging.

Medical Device Revenue: $7.73B                                        Total Employees: ~ 63,751

Founded Year: 1839                                                                   Stock Exchange: Nil 

Market Cap: NA                                                                            Headquarters: Melsungen, Germany

B. Braun Melsungen AG is a German medical and pharmaceutical device company offering a portfolio of anesthesia, intensive care, cardiology, extracorporeal blood treatment, and surgery. In Jan’18 B. Braun received FDA’s approval for 0.9% Sodium Chloride Injection, USP in the Ecoflac Plus 500 mL container. Additionally, B. Braun acquired the bloodlines business of Medisystems name by NxStage Medical Inc.

Medical Device Revenue: $7.93B                                        Total Employees: ~19,000 

Founded Year: 1927                                                                   Stock Exchange: NYSE 

Market Cap: ~$22.97B                                                               Headquarters: Indiana, United States

Zimmer Biomet, a subsidiary of Zimmer Inc., is a global leader in musculoskeletal healthcare that design, manufacture, and markets orthopedic reconstructive products, sports medicine and trauma products, spine, craniomaxillofacial and thoracic products, dental implants and related surgical products. The net sales of 2018 increased by 1.7% in comparison to 2017. In Oct’18 Zimmer Biomet collaborated with Apple to launch a clinical study detailing patient experience and improving joint replacement journey.

Medical Device Revenue: $8.80B                                         Total Employees: ~71,000 

Founded Year: 1969                                                                  Stock Exchange: NYSE 

Market Cap: ~$93.16B                                                             Headquarters: Washington, D.C, United States

Danaher is focused on the design, manufacturing, and marketing of industrial and consumer products. It operates in five segments: Test & Measurement, Dental, Industrial Technologies, Environmental, and Life Science & Diagnostics. Additionally, in Jul’18 the company decided to spin-off its dental portfolio consisting of services and products used to diagnose, treat, prevent disease and ailments of the teeth and gums into an independent business unit which its expected closure in H2’19.

Medical Device Revenue: $9.43B                                       Total Employees: ~103,000 

Founded Year: 1900                                                                   Stock Exchange: NYSE 

Market Cap: ~$133.57B                                                             Headquarters: Illinois, United States

Abbott is a public healthcare company focused on the development, manufacturing, and commercialization of diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. In 2018, Abbott received FDA’s approval for the Advisor HD grid mapping catheter, sensor enabled MitraClip, a heart valve repair device, HeartMate 3 left ventricular assist device (LVAD), XIENCE Sierra drug-eluting stent system.

Medical Device Revenue: $9.82B                                        Total Employees: ~32,000 

Founded Year: 1979                                                                   Stock Exchange: NYSE 

Market Cap: ~$53.47B                                                               Headquarters: Massachusetts, United States

Boston Scientific Corporation is a global developer, manufacturer, and marketer of medical devices used for interventional medical specialties. In early, 2018 Boston acquired NxThera, for the expansion of its Urology and Pelvic Health business with the addition of Rezūm system, used to treat patients with symptomatic benign prostatic hyperplasia (BPH). Additionally, the company has received CE mark approval for its GUIDE XT System used for visualizing of Deep Brain Stimulation (DBS). In Q3’18 Boston acquired BTG to strengthen its peripheral interventions portfolio with minimally-invasive treatments for cancers and vascular conditions.

Medical Device Revenue: $11.12B                                     Total Employees: ~50,000 

Founded Year: 1931                                                                   Stock Exchange: NYSE 

Market Cap: ~$37.84B                                                               Headquarters: Illinois, United States

Baxter is an American health care company focuses on products to treat hemophilia, kidney disease, immune disorders, and other chronic and acute medical conditions. The companies’ medical products unit portfolio contains intravenous products used in the delivery of fluids and drugs to patients, inhalational anesthetics, contract manufacturing services, including products to treat end-stage renal disease and hemodialysis. In Mar’18 Baxter acquired a hemostat and a sealant product from Mallinckrodt, Recothrom Thrombin topical (Recombinant), & Preveleak Surgical Sealant respectively.

Medical Device Revenue: $12.05B                                       Total Employees: ~1,50,000 

Founded Year: 1849                                                                   Stock Exchange: Euronext Paris

Market Cap: ~$50.1B                                                                  Headquarters: Charenton-le-Pont, France

Essilor is a leading firm that designs, manufactures and markets lenses to correct or protect eyesight. In Dec’18 Essilor partnered with Royal Government of Bhutan with the focus to treat patients with unprotected and uncorrected poor vision. Essilor generated an exceeded revenue of 4.6% in comparison to its 2017 revenue.

Medical Device Revenue: $13.4B                                            Total Employees: ~50,000 

Founded Year: 1971                                                                    Stock Exchange: Frankfurt, Xetra 

Market Cap: ~$39.74B                                                               Headquarters: Erlangen, Germany

Siemens Healthineers is a subsidiary of Siemens AG, a diagnostic company focused on the development of diagnostic, therapeutic imaging, laboratory diagnostics, molecular medicine, digital health services, and enterprise services. In Aug’18 Siemens Healthineers collaborated with NuVasive to develop and advance technology designed for minimally invasive spinal surgery. 

Medical Device Revenue: $13.6B                                         Total Employees: ~36,000

Founded Year: 1941                                                                   Stock Exchange: NYSE 

Market Cap: ~$67.90B                                                               Headquarters: Michigan, United States

Stryker is one of the world’s leading medical technology company which offers innovative products and services in Orthopaedics & Spine, Neurotechnology, Medical, and Surgical. In Aug’18 Stryker acquired K2M to strengthen its Spine portfolio offering products in core spinal segment, including an attractive minimally invasive spine portfolio.

Medical Device Revenue: $15.58B                                       Total Employees: ~50,000  

Founded Year: 1971                                                                   Stock Exchange: NYSE 

Market Cap: ~$13.56B                                                               Headquarters: Ohio, United States

Cardinal Health is an American multinational health care services company offering customized solutions for hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The portfolio focuses on Cardiovascular Products, Enteral Feeding, Patient Monitoring, Infection Control, Women and Baby Care products. In Jun’18 Carinal also received FDA’s approval for its INCRAFT AAA Stent Graft System to Treat Infrarenal Abdominal Aortic Aneurysms.

Medical Device Revenue : $15.98B                                     Total Employees: ~76,032

Founded Year: 1895                                                                   Stock Exchange: NYSE 

Market Cap: ~$63B                                                                    Headquarters: New Jersey, United States

Becton, Dickinson, and Company (BD) is a global American medical technology company that manufactures and sells medical devices instrument systems, and reagents. The company is divided into three worldwide segments BD Medical, BD Interventional and BD life sciences offering solutions in Diabetes, Surgeries, Medical Management solutions, and Urology and Critical Care. 

Medical Device Revenue : $18.53B                                       Total Employees: ~112,658

Founded Year: 1996                                                                     Stock Exchange: Xetra    

Market Cap: $22.75B                                                                   Headquarters: Bad Homburg, Germany

Fresenius Medical Care is a global healthcare firm offering solutions in lifesaving medicines, biosimilars and technologies for infusion, transfusion and clinical nutrition. The products and services are used to help care for critically and chronically ill patients. The portfolio offers devices used to deliver I.V. generic drugs, infusion therapies, and clinical nutrition products. In the fields of biosimilars, the portfolio offers treatments for autoimmune diseases and oncology.


Medical Device Revenue : $19.78B                                     Total Employees: ~53,800

Founded Year: 1994                                                                   Stock Exchange: NA

Market Cap: NA                                                                           Headquarters: Illinois, United States

GE Healthcare is a leading global wholly owned subsidiary of General Electric Company focused on the development, manufacturing, and commercialization of healthcare technologies. The portfolio provides solutions and products in diagnosis, treatment, and monitoring of patients. The company has more than 4M imaging, mobile diagnostics and monitoring units installed globally in 43 global centers. GE Healthcare also have an AIR Technology, AI-based technology for intelligent MR slice presentation using artificial neural networks delivering consistent and accurate scans.

Medical Device Revenue: $20.28B                                      Total Employees: ~77,400

Founded Year: 1891                                                                   Stock Exchange: NYSE

Market Cap: $30.66B                                                                 Headquarters: Amsterdam, Netherlands

Royal Philips is a diversified company focusing on improving public health with meaningful innovation offering treatments at a lower cost. Philips Healthcare has focused their research and development efforts to develop new approaches in the areas of radiology, cardiology, oncology, decision support, home health, respiratory and other critical areas. Philips Healthcare@home providing a wide range of healthcare services at the patient’s home with the help of experienced and certified in Basic Life Support (BLS) professionals.

Medical Device Revenue: $26.99B                                        Total Employees: ~135,100

Founded Year: 1886                                                                   Stock Exchange: NYSE

Market Cap: ~$363.93B                                                            Headquarters: New Jersey, United States

J&J is an American multinational medical device, pharmaceutical, and consumer packaged goods manufacturing company. The company’s medical device department focuses on Orthopedics and Cardiovascular Diseases. Its medical device portfolio also offers hip, knee, shoulder replacements techniques including screws, plates, nails and other implants used to treat fractures and deformities related to the extremities and pelvis.

Medical Device Revenue: $30.55B                                         Total Employees: ~90,000

Founded Year: 1949                                                                    Stock Exchange: NYSE

Market Cap: ~$122.42B                                                              Headquarters: Dublin, Ireland

Medtronic is the world’s largest medical device company that majorly focusses on the Cardiac and Vascular Group (CVG), the Restorative Therapies Group (RTG), the Diabetes Group and the Minimally Invasive Therapies Group (MITG). On Nov’18 Medtronic acquired Nutrino Health for its AI-based Continuous Glucose Monitoring (CGM) Technology in addition to the acquisition of Mazor Robotics to transform Spinal technologies and its Outcomes. Medtronic has also received approval for its Valiant Navion Thoracic Stent Graft System to treat Aortic Diseases.